New drug launches and late stage trials will be under the microscope as eight European pharmaceuticals companies report Q1 earnings starting next week.
French and Spanish Stocks were back in the black at noon, leading a partial reversal of earlier losses for the continent as a whole
The maker of the EpiPen seems incapable of overcoming its troubles.
A double victory in oncology failed to lift Astra stock, amid broad weakness in European markets
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.